These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1064 related items for PubMed ID: 19453810

  • 1. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP, Ganslandt C, Tan J, Nordin P, Kragballe K, Segaert S.
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S.
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [Abstract] [Full Text] [Related]

  • 3. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC, Hoffmann V, Anstey A, Barnes L, Bolduc C, Reich K, Saari S, Segaert S, Vaillant L.
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [Abstract] [Full Text] [Related]

  • 4. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC.
    Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
    [Abstract] [Full Text] [Related]

  • 5. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC.
    Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
    [Abstract] [Full Text] [Related]

  • 6. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C, Hoffmann V, Shapiro J, Saari S, Cambazard F, Milsgaard M.
    Dermatology; 2008 May; 217(2):107-13. PubMed ID: 18463448
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 8. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB, Ganslandt C, Ortonne JP, Poulin Y, Burden AD, de Unamuno P, Berne B, Figueiredo A, Austad J.
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [Abstract] [Full Text] [Related]

  • 9. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J, van der Valk PG, Sprangers MA, Damstra RJ, Kunkeler AC, Lijnen RL, Oranje AP, de Rie MA, de Waard-van der Spek FB, Hol CW, van de Kerkhof PC.
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [Abstract] [Full Text] [Related]

  • 10. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    Duweb GA, Abuzariba O, Rahim M, al-Taweel M, Abdulla SA.
    Int J Clin Pharmacol Res; 2000 Feb; 20(3-4):65-8. PubMed ID: 11314240
    [Abstract] [Full Text] [Related]

  • 11. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
    Saraceno R, Andreassi L, Ayala F, Bongiorno MR, Giannetti A, Lisi P, Martini P, Peris K, Peserico A, Chimenti S.
    J Dermatolog Treat; 2007 Feb; 18(6):361-5. PubMed ID: 17934937
    [Abstract] [Full Text] [Related]

  • 12. Significant one week efficacy of a calcipotriol plus betamethasone dipropionate scalp formulation.
    Jemec GB, van de Kerkhof PC, Enevold A, Ganslandt C.
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):27-32. PubMed ID: 20456557
    [Abstract] [Full Text] [Related]

  • 13. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
    Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G.
    Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
    [Abstract] [Full Text] [Related]

  • 14. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
    Fleming C, Ganslandt C, Guenther L, Johannesson A, Buckley C, Simon JC, Stegmann H, Vestergaard Tingleff L.
    Eur J Dermatol; 2010 Jun; 20(4):465-71. PubMed ID: 20413372
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L, Cutler TP, Helander I, Nyfors B, Downes N.
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [Abstract] [Full Text] [Related]

  • 16. Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product.
    Cassano N, Vena GA.
    Acta Derm Venereol; 2007 Jan; 87(1):85-6. PubMed ID: 17225026
    [No Abstract] [Full Text] [Related]

  • 17. Use of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasis.
    Queille-Roussel C, Hoffmann V, Enevold A, Ganslandt C.
    J Dermatolog Treat; 2013 Aug; 24(4):250-4. PubMed ID: 22103604
    [Abstract] [Full Text] [Related]

  • 18. Effective treatment and improvement of quality of life in patients with scalp psoriasis by topical use of calcipotriol/betamethasone (Xamiol®-gel): results.
    Mrowietz U, Macheleidt O, Eicke C.
    J Dtsch Dermatol Ges; 2011 Oct; 9(10):825-31. PubMed ID: 21564540
    [Abstract] [Full Text] [Related]

  • 19. Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp.
    Kragballe K, van de Kerkhof P.
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():10-21. PubMed ID: 24684739
    [Abstract] [Full Text] [Related]

  • 20. Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.
    Poulin Y.
    Skin Therapy Lett; 2002 Jun; 7(6):1-3. PubMed ID: 12223976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.